Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

ACTIVE NOT RECRUITING

NCT07238179

Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis

Sponsor: Universitaire Ziekenhuizen KU Leuven

View on ClinicalTrials.gov

Summary

ITM has the potential to be a powerful tool for multimodal postoperative pain management, understanding, preventing and managing its side effects is crucial for upturn of patient safety and comfort. This retrospective audit will therefore be focused on the most reported side effects in daily clinical practice in patients having received ITM. The results of this study may lead to new insights into the clinically relevant risk-benefit balance of ITM and will contribute to the optimisation of its use in clinical practice.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

600

Start Date

2021-03-01

Completion Date

2025-12-31

Last Updated

2025-11-20

Healthy Volunteers

Conditions

Morphine Morphine Adverse Reaction Morphine Induced Pruritis Nausea and Vomiting, Postoperative Analgesia Spinal Analgesia

Interventions

DRUG

Intrathecal Morphine

The administration of intrathecal morphine (2µg/kg, with a maximum of 150-200µg) according to standard practice in a variety of surgical procedures. In addition, patients of 2 RCT using 4 or 5µg/kg (max 400 or 500µg), will also be included.

Locations (1)

University Hospitals Leuven

Leuven, Belgium